• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

限制钠饮食对肝硬化腹水患者腹水的影响。

Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis.

机构信息

Department of Liver Disease, Wuxi Hospital for Infectious Diseases, Wuxi, China.

出版信息

Gut Liver. 2012 Jul;6(3):355-61. doi: 10.5009/gnl.2012.6.3.355. Epub 2012 Jul 12.

DOI:10.5009/gnl.2012.6.3.355
PMID:22844565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3404174/
Abstract

BACKGROUND/AIMS: There has been debate on whether a sodium-restricted diet (SRD) should be used in cirrhotic patients with ascites in China in recent years. The purpose of this study was to compare the effect of sodium-restricted and unrestricted diets on plasma renin activity (PRA), renal blood flow (RBF) and ascites in patients with liver cirrhosis.

METHODS

Two hundred cirrhotic patients with ascites were randomly divided into two groups (98 cases in the sodium-unrestricted diet [SUD] group and 102 cases in the SRD group); 95 patients (96.94%) in the SUD group and 97 patients (95.1%) in the SRD group had post-hepatitis B cirrhosis.

RESULTS

Blood sodium and RBF were higher in SUD group than in SRD group (p<0.001), while PRA were significantly lower in SUD group than the SRD group 10 days after treatment (p<0.001). Renal impairment caused by low blood sodium was higher in SRD group than in SUD group (p<0.01). Ascites disappeared in higher proportion of patients in SUD group than in SRD group (p<0.001).

CONCLUSIONS

SUD can increase the level of blood sodium and RBF, and be beneficial to diuresis and ascite reduction and disappearance.

摘要

背景/目的:近年来,中国对于肝硬化伴腹水患者是否应采用限钠饮食一直存在争议。本研究旨在比较限钠和不限钠饮食对肝硬化患者血浆肾素活性(PRA)、肾血流量(RBF)和腹水的影响。

方法

将 200 例肝硬化腹水患者随机分为两组(限钠饮食组[SUD]98 例,SRD 组 102 例);SUD 组 95 例(96.94%),SRD 组 97 例(95.1%)为乙型肝炎后肝硬化。

结果

SUD 组血钠和 RBF 均高于 SRD 组(p<0.001),而治疗 10 天后 SUD 组 PRA 明显低于 SRD 组(p<0.001)。SRD 组因低血钠引起的肾功能损害高于 SUD 组(p<0.01)。SUD 组腹水消失的患者比例高于 SRD 组(p<0.001)。

结论

SUD 可增加血钠和 RBF 水平,有利于利尿和减少腹水。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734c/3404174/0e1e72dee7c4/gnl-6-355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734c/3404174/0e1e72dee7c4/gnl-6-355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734c/3404174/0e1e72dee7c4/gnl-6-355-g001.jpg

相似文献

1
Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis.限制钠饮食对肝硬化腹水患者腹水的影响。
Gut Liver. 2012 Jul;6(3):355-61. doi: 10.5009/gnl.2012.6.3.355. Epub 2012 Jul 12.
2
[Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].[非限钠饮食联合利尿剂对肝硬化腹水患者血浆肾素、肾血流量的影响]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Feb;27(1):50-3.
3
Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.代偿期肝硬化患者对钠限制的交感神经和肾脏反应异常。
Gastroenterology. 1991 Nov;101(5):1354-60. doi: 10.1016/0016-5085(91)90088-3.
4
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.白蛋白可改善肝硬化腹水患者对利尿剂的反应:一项随机对照试验的结果。
J Hepatol. 1999 Apr;30(4):639-45. doi: 10.1016/s0168-8278(99)80194-9.
5
Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings.肝硬化和腹水时交感神经输出增加:神经内记录的直接证据
Ann Intern Med. 1991 Mar 1;114(5):373-80. doi: 10.7326/0003-4819-114-5-373.
6
Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.肝硬化腹水患者中度体育锻炼期间的肾功能损害:与神经激素系统活性的关系
Hepatology. 1997 Jun;25(6):1338-42. doi: 10.1002/hep.510250606.
7
[Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].[肝硬化腹水患者的肾小管功能:特别提及人心房利钠肽给药后的锂清除率]
Nihon Jinzo Gakkai Shi. 1991 Aug;33(8):791-801.
8
[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].[卡托普利治疗对肝硬化腹水患者钠和水排泄的影响]
Klin Wochenschr. 1989 Aug 1;67(15):774-83. doi: 10.1007/BF01745350.
9
Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.丙型肝炎病毒相关肝硬化患者的肾脏双功多普勒超声检查
Trop Gastroenterol. 2009 Oct-Dec;30(4):213-8.
10
Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.肝硬化腹水患者对[1-肌氨酸,8-异亮氨酸]血管紧张素II的血压反应。
Jpn Circ J. 1979 Jan;43(1):37-41. doi: 10.1253/jcj.43.37.

引用本文的文献

1
Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites.限盐对肝硬化腹水患者营养状况、肌肉减少症和死亡率的影响。
BMC Gastroenterol. 2025 Jul 15;25(1):521. doi: 10.1186/s12876-025-03830-1.
2
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.美国胃肠病学会临床指南:肝病中的营养不良与营养建议
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
3
Role of Nutrition in the Management of Chronic Liver Disease.

本文引用的文献

1
Salt restriction in ascites with cirrhosis of liver: will enhanced salt restriction increase longevity?肝硬化腹水患者的限盐:强化限盐会延长寿命吗?
J Assoc Physicians India. 2006 Jun;54:504.
2
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis.一种预测四氯化碳诱导的肝硬化大鼠腹水失代偿的新型钠超载试验。
J Hepatol. 2005 Jul;43(1):92-7. doi: 10.1016/j.jhep.2005.01.034. Epub 2005 Apr 9.
3
[Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
营养在慢性肝病管理中的作用。
Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025.
4
Current and emerging therapies for alcohol-associated hepatitis.酒精性肝炎的现有及新兴疗法
Liver Res. 2023 Mar 15;7(1):35-46. doi: 10.1016/j.livres.2023.03.002. eCollection 2023 Mar.
5
Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse.肝硬化治疗中易被忽视的因素:病情恶化的隐匿元凶
Prz Gastroenterol. 2024;19(1):6-17. doi: 10.5114/pg.2024.136361. Epub 2024 Mar 14.
6
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.基于病理生理学的营养干预在伴有肌肉减少症的肝硬化患者中的应用:最新的叙述性综述。
Nutrients. 2024 Jan 31;16(3):427. doi: 10.3390/nu16030427.
7
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.终末期肝病中的衰弱:了解病理生理学、评估工具和管理策略。
World J Gastroenterol. 2023 Dec 14;29(46):6028-6048. doi: 10.3748/wjg.v29.i46.6028.
8
Dietary salt in liver cirrhosis: With a pinch of salt!肝硬化中的膳食盐:需谨慎对待!
World J Hepatol. 2023 Oct 27;15(10):1084-1090. doi: 10.4254/wjh.v15.i10.1084.
9
Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension.慢性肝病患者血清钠水平轻度降低:存在肌肉减少症和门静脉高压的风险
Cureus. 2023 Aug 30;15(8):e44419. doi: 10.7759/cureus.44419. eCollection 2023 Aug.
10
Salt consumption and mortality risk in cirrhotic patients: results from a cohort study.肝硬化患者的盐摄入量与死亡率风险:一项队列研究的结果。
J Nutr Sci. 2022 Nov 8;11:e99. doi: 10.1017/jns.2022.69. eCollection 2022.
Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):370.
4
Management of adult patients with ascites due to cirrhosis.肝硬化所致腹水成年患者的管理
Hepatology. 2004 Mar;39(3):841-56. doi: 10.1002/hep.20066.
5
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.肝硬化腹水的管理:国际腹水俱乐部共识会议报告
Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315.
6
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.低剂量氯沙坦改善腹水前期肝硬化钠稳态的机制
Hepatology. 2002 Jun;35(6):1449-58. doi: 10.1053/jhep.2002.33637.
7
New challenge of hepatorenal syndrome: prevention and treatment.肝肾综合征的新挑战:预防与治疗
Hepatology. 2001 Dec;34(6):1242-51. doi: 10.1053/jhep.2001.29200.
8
Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.利水剂:肝硬化稀释性低钠血症的一种新的潜在治疗方法。
J Hepatol. 1996 Apr;24(4):506-12. doi: 10.1016/s0168-8278(96)80174-7.
9
Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases.重度症状性低钠血症:治疗与转归。一项64例病例的研究。
Ann Intern Med. 1987 Nov;107(5):656-64. doi: 10.7326/0003-4819-107-5-656.
10
Salt or no salt in the treatment of cirrhotic ascites: a randomised study.肝硬化腹水治疗中使用或不使用盐:一项随机研究。
Gut. 1986 Jun;27(6):705-9. doi: 10.1136/gut.27.6.705.